- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Recurrent or Metastatic Bladder Cancer
Total 10708 results
-
National Cancer Institute (NCI)CompletedStage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal CancerUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
NATCO Pharma Ltd.RecruitingCarcinoma | Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaUnited States, India
-
Shanghai Miracogen Inc.RecruitingRecurrent or Metastatic Nasopharyngeal CarcinomaChina
-
Seoul National University HospitalCompletedRecurrent or Metastatic Nasopharyngeal CarcinomKorea, Republic of
-
Sun Yat-sen UniversityActive, not recruitingNasopharyngeal Carcinoma | Recurrent or Metastatic Nasopharyngeal CarcinomaChina
-
UNICANCERNational Cancer Institute, FranceRecruitingMetastatic Lung Cancer | Metastatic Breast Cancer | Bone Metastases | Metastatic Prostate CancerFrance
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedVaginal Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Advanced Cervical Adenocarcinoma | Human Papillomavirus-Related Cervical Squamous Cell Carcinoma | Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma | Stage III Cervical Cancer AJCC v8 | Stage IIIA... and other conditionsUnited States
-
The First Affiliated Hospital with Nanjing Medical...UnknownRecurrence | Bladder Cancer | Prognosis | Gemcitabine and Cisplatin Chemotherapy | Epirubicin InstillationChina
-
Peking University First HospitalRecruitingUrinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder Tumors | Neoplasms, BladderChina
-
Seoul National University Bundang HospitalSeoul National University Hospital; SMG-SNU Boramae Medical Center; Yuhan Pharmaceutical... and other collaboratorsCompletedMetastatic or Recurrent Colorectal Cancer | Refractory to Fluoropyrimidine, Oxaliplatin and Irinotecan | Salvage ChemotherapyKorea, Republic of
-
UNC Lineberger Comprehensive Cancer CenterRecruiting
-
Proviva Therapeutics, Inc.Not yet recruitingSolid Tumor | Metastatic Cancer | Advanced Cancer
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMSI | dMMR Colorectal CancerFrance
-
Qurient Co., Ltd.RecruitingSolid Tumor | Metastatic Cancer | Advanced CancerUnited States
-
I-Mab Biopharma Co. Ltd.CompletedSolid Tumor | Metastatic Cancer | Advanced CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMetastatic Cancer | Advanced CancerUnited States
-
Institut Cancerologie de l'OuestCompletedToxicity | Pancreatic Metastatic CancerFrance
-
University of California, DavisNational Institutes of Health (NIH)RecruitingMetastatic CancerUnited States
-
ElsanNot yet recruiting
-
Matthias GuckenbergerRecruitingMetastatic CancerSwitzerland
-
University Hospital AugsburgRecruitingNeoplasms | Neoplasm Metastasis | Metastatic CancerGermany
-
SOLTI Breast Cancer Research GroupDaiichi Sankyo, Inc.Recruiting
-
Matrix Biomed, Inc.Available
-
Amsterdam UMC, location VUmcImmunovo B.V.Completed
-
Jonsson Comprehensive Cancer CenterCompletedMetastatic CancerUnited States
-
Jonsson Comprehensive Cancer CenterSchering-PloughCompletedMetastatic CancerUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Completed
-
Fundacao ChampalimaudUnknown
-
Gustave Roussy, Cancer Campus, Grand ParisCompleted
-
Boston Medical CenterUnited States Department of DefenseCompletedMetastatic CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMetastatic CancerUnited States
-
Samsung Medical CenterCompletedMetastatic CancerKorea, Republic of
-
Recepta BiopharmaCompleted
-
Duke UniversityCompletedMetastatic CancerUnited States
-
Lahey ClinicTerminatedMetastatic CancerUnited States
-
Cancer Trials IrelandRecruitingPrimary Breast Cancer | Recurrent/Metastatic Breast CancerIreland
-
Centre for Probe Development and CommercializationMcDougall Scientific Ltd.CompletedRecurrent Prostate Cancer | Prostate Cancer RecurrentCanada
-
AstraZenecaCompletedBreast Cancer Nos Metastatic RecurrentRomania
-
University Health Network, TorontoRecruiting
-
NRG OncologyNational Cancer Institute (NCI)TerminatedStage III Bladder Cancer | Stage IV Bladder CancerCanada, United States, Israel
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Korea, Republic of, China, Spain, Taiwan, Japan, Argentina, Canada, Croatia, Greece, Ireland, Malaysia, Netherlands, Portugal, Romania, Thailand, Turkey, United Kingdom
-
William Beaumont HospitalsCompletedBladder Cancer
-
Duke UniversityTerminatedAdvanced Cancer | Brain Metastasis | Metastatic Cancer Patients on an Anti-cancer TherapyUnited States
-
Jazz PharmaceuticalsRecruitingSolid Tumor | Metastatic Cancer | Advanced CancerUnited States
-
Jiangxi Provincial Cancer HospitalRecruitingMetastatic CancerChina
-
Gustave Roussy, Cancer Campus, Grand ParisRoche Pharma AGRecruiting
-
Milton S. Hershey Medical CenterCompleted
-
Hoffmann-La RocheCompletedNeoplasmsUnited States, France, Spain, Korea, Republic of, United Kingdom